Trading Signals
Merck HIV Drug Trial Data at AIDS 2026: What Traders Need to Know Before the Catalyst Hits
Merck is set to present pivotal HIV treatment trial data at a major AIDS conference, creating a high-stakes binary catalyst for MRK shares and the broader biotech sector. Traders need to understand the mechanism, the key price levels, and the correlated instruments before the data drops.